Corporate News - Archive

| Investor News

  • Proposed dividend of EUR 5.00 per share (previous year: EUR 1.20), to be approved at the Annual General Meeting on 9 July 2026
  • Net loss for the period of EUR 52.0 million (same quarter last year: EUR 20.0 million), primarily due to the non-cash fair value measurement of the investment in M1 Kliniken AG
  • Equity ratio remains very high: 91.9% (previous year, 31 December 2025: 94.3%)
  • M1 Kliniken AG’s beauty division reports a strong first quarter of 2026: revenue up 5.7% to EUR 27.1 million, EBIT up 37.6% to EUR 9.2 million, EBIT margin at 33.9% (same quarter last year: 26.0%)    

| Investor News

  • Equity ratio remains very high: 94.3% (previous year: 95.5%)
  • Net loss for the year of €29.3 million, primarily due to a non-cash one-off item arising from the fair value measurement of the CR Energy investment
  • Key holding M1 Kliniken AG reports strong financial year 2025: EBIT up 29%,
    „Beauty“ segment exceeds €100 million in revenue for the first time
  • Increased dividend of €5.00 per share proposed (previous year: €1.20)

| Investor News

At today's balance sheet meeting, the Supervisory Board of MPH Health Care AG (ISIN: DE000A289V03) approved the annual financial statements and the consolidated financial statements of the Company for the 2025 financial year, as submitted by the Management Board, in accordance with §§ 171, 172 AktG. The annual financial statements are thereby adopted pursuant to § 172 AktG.

The Supervisory Board and the Management Board today resolved to propose to the Annual General Meeting a dividend of EUR 5.00 per dividend-bearing share.

The 2025 Annual Report of MPH Health Care AG is expected to be published on 27 May 2026.

| Investor News

  • Equity ratio remains stable at well over 90% (94.3% compared with 95.5%)
  • Net loss for the year of €29.3 million primarily due to the non-cash fair value measurement of the CR Energy investment
  • Core investment M1 Kliniken AG reports strong operating performance: EBIT +29%, Beauty segment exceeds €100 million in revenue for the first time
  • Management Board confirms confident outlook for 2026

| Investor News

MPH Health Care AG (ISIN: DE000A289V03) announces its preliminary IFRS consolidated results for the third quarter of 2025. According to this, equity decreased by 30% from EUR 277.9 million as of 31 December 2024 to EUR 194.2 million as of 30 September 2025. Net asset value (NAV) per share fell from EUR 64.90 (31 December 2024) to EUR 45.36 as of 30 September 2025

| Investor News

MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated results for the first half-year of 2025. Accordingly, equity decreased by 26% from EUR 277.9 million as of 31 December 2024 to EUR 205.1 million as of 30 June 2025. The net asset value (NAV) per share fell from EUR 64.90 (31 December 2024) to EUR 47.91 as of 30 June 2025.

| Investor News

  • Equity (net asset value) amounts to EUR 257.9 million, which corresponds to EUR 60.24 per share.
  • Equity ratio decreases slightly to 94.9% (31 December 2024: 95.5%)

| Investor News

  • Net profit (IFRS) increases to EUR 32.0 mn (previous year: EUR 29.5 mn)
  • EBIT increases by 9.1% to EUR 33.0 mn (previous year: EUR 30.2 mn)
  • Equity ratio: increase from 94.2% to 95.5%
  • Equity increases from EUR 251.0 mn to EUR 277.9 mn as of 31 December 2024

| Investor News

MPH Health Care AG announces the preliminary IFRS consolidated result for the 2024 financial year. Accordingly, equity increased by 10.7% from EUR 251.0 million to EUR 277.9 million. The net asset value (NAV) per share rose from EUR 58.62 (31 December 2023) to EUR 64.90 as of 31 December 2024.

| Investor News

MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated result for the first nine months of the 2024 financial year. Accordingly, equity increased by EUR 49.3 million to EUR 300.3 million as of 30 September 2024 (previous year 31 December 2023: EUR 251.0 million). The net asset value (NAV) per share increased by 39% year-over-year from EUR 50.38 (30/09/2023) to EUR 70.14 as of 30/09/2024.